Education
About Us
Working with TipRanks
Follow Us
Imunon (IMNN)
NASDAQ:IMNN
Total Valuation
Imunon has a market cap or net worth of $12.74M. The enterprise value is $11.79M.
Market Cap$12.74M
Enterprise Value$11.79M
Share Statistics
Imunon has 3,070,354 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding3,070,354
Owned by Insiders12.23%
Owned by Institutions2.91%
Financial Efficiency
Imunon’s return on equity (ROE) is -4.39 and return on invested capital (ROIC) is -355.38%.
Return on Equity (ROE)-4.39
Return on Assets (ROA)-1.92
Return on Invested Capital (ROIC)-355.38%
Return on Capital Employed (ROCE)-3.88
Revenue Per Employee0.00
Profits Per Employee-744.81K
Employee Count25
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Imunon is ―. Imunon’s PEG ratio is 0.03.
PE Ratio―
PS Ratio0.00
PB Ratio2.96
Price to Fair Value2.96
Price to FCF-0.67
Price to Operating Cash Flow>-0.01
PEG Ratio0.03
Income Statement
In the last 12 months, Imunon had revenue of 0.00 and earned -18.62M in profits. Earnings per share was -21.10.
Revenue0.00
Gross Profit0.00
Operating Income-19.13M
Pretax Income-18.62M
Net Income-18.62M
EBITDA-17.90M
Earnings Per Share (EPS)-21.10
Cash Flow
In the last 12 months, operating cash flow was -14.66M and capital expenditures -291.89K, giving a free cash flow of -14.95M billion.
Operating Cash Flow-14.66M
Free Cash Flow-14.95M
Free Cash Flow per Share-4.87
Dividends & Yields
Imunon pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.43
52-Week Price Change-64.90%
50-Day Moving Average4.35
200-Day Moving Average8.83
Relative Strength Index (RSI)45.78
Average Volume (3m)131.31K
Important Dates
Imunon upcoming earnings date is Mar 26, 2026, TBA (Confirmed).
Last Earnings DateNov 13, 2025
Next Earnings DateMar 26, 2026
Ex-Dividend Date―
Financial Position
Imunon as a current ratio of 1.67, with Debt / Equity ratio of 27.00%
Current Ratio1.67
Quick Ratio1.67
Debt to Market Cap0.00
Net Debt to EBITDA0.26
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Imunon has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Imunon EV to EBITDA ratio is -0.44, with an EV/FCF ratio of -0.42.
EV to Sales0.00
EV to EBITDA-0.44
EV to Free Cash Flow-0.42
EV to Operating Cash Flow-0.42
Balance Sheet
Imunon has $5.25M in cash and marketable securities with $1.10M in debt, giving a net cash position of $4.15M billion.
Cash & Marketable Securities$5.25M
Total Debt$1.10M
Net Cash$4.15M
Net Cash Per Share$1.35
Tangible Book Value Per Share$4.81
Margins
Gross margin is 0.13%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.13%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Imunon is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside202.27% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast57.97%